Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 23 member 3 (SLC23A3), also known as SVCT3, is a member of the sodium-dependent vitamin C transporter family. While SLC23A1 (SVCT1) and SLC23A2 (SVCT2) are high-affinity, high-capacity ascorbate (vitamin C) transporters critical for vitamin C homeostasis, SLC23A3 is considered an orphan transporter with no reported vitamin C transport activity in humans[1][2][4]. Recent evidence suggests SLC23A3 instead acts as a sodium-dependent hypoxanthine transporter and may possess xanthine-hypoxanthine exchange activity, indicating a role in purine metabolism[7]. The gene is phylogenetically aligned with the nucleobase-ascorbate transporter (NAT) family, but its precise physiologic role in humans remains to be clarified. There are currently no validated disease associations or drugs targeting SLC23A3 directly.
Sodium-dependent cotransport (putative; hypoxanthine transport); May participate in xanthine-hypoxanthine exchange.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 23 member 3 (SLC23A3).